Related Experiment Video
Updated: May 18, 2026
10:21
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Genotype-phenotype interactions in the myeloproliferative neoplasms
Anna L Godfrey1, Anthony R Green
1Cambridge Institute for Medical Research and Department of Haematology, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK.
Hematology/Oncology Clinics of North America
|September 27, 2012
Summary
Chronic myeloproliferative neoplasms (MPNs) involve myeloid cell overproduction. This review explores genetic factors influencing MPN phenotypes, distinguishing between low-complexity ET/PV and high-complexity myelofibrosis or blast-phase disease.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Chronic myeloproliferative neoplasms (MPNs) are clonal hematologic disorders characterized by the overproduction of mature myeloid cells.
- MPNs share molecular abnormalities, notably the JAK2V617F mutation, yet exhibit distinct phenotypic differences.
- Understanding these differences is crucial for accurate diagnosis and treatment strategies.
Purpose of the Study:
- To review factors influencing MPN phenotypes, particularly in JAK2-mutated cases like polycythemia vera (PV) and essential thrombocythemia (ET).
- To discuss mutations implicated in JAK2-negative MPNs, including those in MPL and epigenetic regulators.
- To present a model for MPN progression based on genetic complexity.
Main Methods:
- Literature review of studies on MPN genetics and phenotypes.
- Analysis of molecular data, including JAK2, MPL, and epigenetic regulator mutations.
- Synthesis of evidence to support a model of MPN evolution.
Main Results:
- JAK2-mutated MPNs, specifically PV and ET, are generally characterized by lower genetic complexity.
- JAK2-negative MPNs involve mutations in other key genes like MPL and epigenetic regulators.
- Progression to advanced MPN phases (myelofibrosis, blast-phase) is associated with an increased mutation burden.
Conclusions:
- MPN phenotypes are influenced by a combination of genetic mutations and their complexity.
- ET and PV represent early stages of MPN with relatively simple genetic profiles.
- The accumulation of genetic mutations drives the evolution of MPNs towards more aggressive forms.
More Related Videos
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:49Multiple Allele Traits
The Concept of Multiple Allelism
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:27Background and Environment Affect Phenotype
Although the genetic makeup of an organism plays a major role in determining the phenotype, there are also several environmental factors, such as temperature, oxygen availability, presence of mutagens, that can alter an organism’s phenotype.
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...